Outcomes and quality of life in patients receiving durable left ventricular assist device with biventricular support
Patients requiring BIVAD therapy have more advanced shock, longer associated hospital courses, and lower long-term survival. However, those that survive enjoy similar overall quality of life, and many endorse positive outlooks on their surgical course. Continued assessments of quality of life are important in providing patient-centered LVAD care.
Authors
- David Rekhtman (ORCID: https://orcid.org/0000-0001-7169-8950)
- Pavan Atluri (ORCID: https://orcid.org/0000-0003-0229-085X)
- Mark R. Helmers (ORCID: https://orcid.org/0000-0003-1573-6697)
- Joyce Wald (ORCID: https://orcid.org/0000-0003-0276-3709)
- Marisa Cevasco (ORCID: https://orcid.org/0000-0002-0075-2574)
- Noah Weingarten (ORCID: https://orcid.org/0000-0003-3813-7355)
- Amit Iyengar
- Cindy Song
- Max Shin (ORCID: https://orcid.org/0000-0002-2748-3052)
Institutions
- University of Pennsylvania (US)
Publication Details
- Journal
- Artificial Organs
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1111/aor.14835
- Citations
- 2
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.37